The plan is directed to identification of a test or tests which can distinguish the asymptomatic carrier of AIDS from healthy controls. It is assumed that AIDS can be transmitted by an infectious agent during the asymptomatic incubation period or in a chronic healthy carrier state. The tests will be evaluated in populations with a high probability of including asymptomatic carriers: (1) blood donors to patients who developed AIDS, (2) recipients of blood from donors who develop AIDS, and (3) 1,000 prospectively followed homesexually-active males, of which 30 to 60 will probably develop AIDS during the study. Appropriate controls will be studied in the same way. Serologic tests to be evaluated include thymosin alpha-1, thymosin beta-4, beta-2 microglobulin, acid-labile alpha interferon, tests for HTLV, anti-HBc and anti-CMV, as well as others which become available later. HLA typing will be done on a selected group for evidence of genetic susceptibility. New approaches to detecting asymptomatic carriers of AIDS will be developed from flow cytometry studies using not only standard reagents but also new monoclonal antibodies identifying other mononuclear subpopulations. Simultaneous two-color fluorescent cytometry will permit identification of subpopulations with markers which may be associated with AIDS. If successful, the tests can be used to identify asymptomatic carriers of AIDS, prevent their dissemination of the disease by inappropriate contacts or blood donation, and indicate high-risk subjects who should be observed closely for evidence of AIDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032477-03
Application #
3343814
Study Section
(SRC)
Project Start
1984-05-15
Project End
1987-04-30
Budget Start
1986-05-01
Budget End
1987-04-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
San Francisco Medical Society
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Krowka, J F; Singh, B; Stites, D P et al. (1991) Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals. Clin Immunol Immunopathol 59:53-64
Krowka, J F; Stites, D P; Jain, S et al. (1989) Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest 83:1198-203
Moody, D J; Casavant, C H; Fulwyler, M J et al. (1988) Multiparameter flow cytometric analysis of mononuclear cells from HIV-infected individuals. Cytometry Suppl 3:44-7
Krowka, J F; Stites, D P; Moss, A R et al. (1988) Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco. Diagn Clin Immunol 5:381-7
Perkins, H A; Samson, S; Garner, J et al. (1987) Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS. Blood 70:1604-10
McHugh, T M; Stites, D P; Casavant, C H et al. (1986) Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus. Diagn Immunol 4:233-40
Stites, D P; Casavant, C H; McHugh, T M et al. (1986) Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence. Clin Immunol Immunopathol 38:161-77